Switch to:
Alexion Pharmaceuticals Inc (NAS:ALXN)
Piotroski F-Score
4 (As of Today)

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Alexion Pharmaceuticals Inc has an F-score of 4 indicating the company's financial situation is typical for a stable company.

ALXN' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Max: 8
Current: 4

1
8

During the past 13 years, the highest Piotroski F-Score of Alexion Pharmaceuticals Inc was 8. The lowest was 1. And the median was 4.


Definition

How is the Piotroski F-Score calculated?

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

This Year (Mar16) TTM:Last Year (Mar15) TTM:
Net Income was 170.215 + -183.757 + 66.604 + 92.166 = $145 Mil.
Cash Flow from Operations was 238.222 + 223.086 + 190.857 + 167.984 = $820 Mil.
Revenue was 636.21 + 666.637 + 700.867 + 701.038 = $2,705 Mil.
Gross Profit was 584.203 + 612.58 + 643.241 + 642.052 = $2,482 Mil.
Average Total Assets from the begining of this year (Mar15)
to the end of this year (Mar16) was
(4414.925 + 13167.719 + 13153.015 + 13133.23 + 12802.445) / 5 = $11334.2668 Mil.
Total Assets at the begining of this year (Mar15) was $4,415 Mil.
Long-Term Debt was $3,386 Mil.
Total Current Assets was $2,128 Mil.
Total Current Liabilities was $604 Mil.
Net Income was 166.495 + 177.731 + 153.332 + 91.323 = $589 Mil.

Revenue was 512.495 + 555.146 + 599.476 + 600.333 = $2,267 Mil.
Gross Profit was 472.869 + 503.288 + 550.037 + 530.934 = $2,057 Mil.
Average Total Assets from the begining of last year (Mar14)
to the end of last year (Mar15) was
(3379.666 + 3553.81 + 3890.887 + 4201.962 + 4414.925) / 5 = $3888.25 Mil.
Total Assets at the begining of last year (Mar14) was $3,380 Mil.
Long-Term Debt was $115 Mil.
Total Current Assets was $2,853 Mil.
Total Current Liabilities was $580 Mil.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Alexion Pharmaceuticals Inc's current net income (TTM) was 145. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Alexion Pharmaceuticals Inc's current cash flow from operations (TTM) was 820. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year’s return on assets (1) to last year’s return on assets.

Score 1 if it’s higher, 0 if it’s lower.

ROA (This Year)=Net Income (TTM)/Total Assets at the Beginning of This Year (Mar15)
=145.228/4414.925
=0.03289478

ROA (Last Year)=Net Income (TTM)/Total Assets at the Beginning of Last Year (Mar14)
=588.881/3379.666
=0.17424237

Alexion Pharmaceuticals Inc's return on assets of this year was 0.03289478. Alexion Pharmaceuticals Inc's return on assets of last year was 0.17424237. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Alexion Pharmaceuticals Inc's current net income (TTM) was 145. Alexion Pharmaceuticals Inc's current cash flow from operations (TTM) was 820. ==> 820 > 145 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year’s gearing (long-term debt divided by average total assets) to last year’s gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar16)=Long-Term Debt/Average Total Assets from Mar15 to Mar16
=3385.742/11334.2668
=0.29871734

Gearing (Last Year: Mar15)=Long-Term Debt/Average Total Assets from Mar14 to Mar15
=114.912/3888.25
=0.02955366

Alexion Pharmaceuticals Inc's gearing of this year was 0.29871734. Alexion Pharmaceuticals Inc's gearing of last year was 0.02955366. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year’s current ratio (current assets divided by current liabilities) to last year’s current ratio.

Score 1 if this year'’s current ratio is higher, 0 if it’s lower

Current Ratio (This Year: Mar16)=Total Current Assets/Total Current Liabilities
=2127.509/603.613
=3.52462422

Current Ratio (Last Year: Mar15)=Total Current Assets/Total Current Liabilities
=2852.987/580.439
=4.91522279

Alexion Pharmaceuticals Inc's current ratio of this year was 3.52462422. Alexion Pharmaceuticals Inc's current ratio of last year was 4.91522279. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Alexion Pharmaceuticals Inc's number of shares in issue this year was 226.9. Alexion Pharmaceuticals Inc's number of shares in issue last year was 202. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year’s gross margin (gross profit divided by sales) to last year’s.

Score 1 if this year’s gross margin is higher, 0 if it’s lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=2482.076/2704.752
=0.9176723

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=2057.128/2267.45
=0.90724294

Alexion Pharmaceuticals Inc's gross margin of this year was 0.9176723. Alexion Pharmaceuticals Inc's gross margin of last year was 0.90724294. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year’s asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year’s asset turnover ratio.

Score 1 if this year’s asset turnover ratio is higher, 0 if it’s lower

Asset Turnover (This Year)=Revenue (TTM)/Total Assets at the Beginning of This Year (Mar15)
=2704.752/4414.925
=0.61263827

Asset Turnover (Last Year)=Revenue (TTM)/Total Assets at the Beginning of Last Year (Mar14)
=2267.45/3379.666
=0.67090949

Alexion Pharmaceuticals Inc's asset turnover of this year was 0.61263827. Alexion Pharmaceuticals Inc's asset turnover of last year was 0.67090949. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+0+0+1+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Alexion Pharmaceuticals Inc has an F-score of 4 indicating the company's financial situation is typical for a stable company.


Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Related Terms

Net Income, Cash Flow from Operations, Revenue, Gross Profit, Total Assets, Long-Term Debt, Total Current Assets, Total Current Liabilities


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Alexion Pharmaceuticals Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
Question 1 0011111111
Question 2 0011111111
Question 3 0111011010
Question 4 1010111101
Question 5 0111110110
Question 6 0001101010
Question 7 0000000000
Question 8 0000011010
Question 9 1111011010
F-score 2366577473

Alexion Pharmaceuticals Inc Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
Question 1 1111111111
Question 2 1111111111
Question 3 0001111000
Question 4 1111011111
Question 5 1111100000
Question 6 0111100000
Question 7 0000000000
Question 8 0001110001
Question 9 0111110000
F-score 4668764334
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK